{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:45:32Z","timestamp":1770745532532,"version":"3.49.0"},"reference-count":64,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"unspecified","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Trans. Sci."],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Given the convergence of the long and challenging development path for medical devices with the need for diagnostic capabilities for mild traumatic brain injury (mTBI\/concussion), the effective role of public\u2013private partnership (PPP) can be demonstrated to yield Food and Drug Administration (FDA) clearances and innovative product introductions. An overview of the mTBI problem and landscape was performed. A detailed situation analysis of an example of a PPP yielding an innovative product was further demonstrated. The example of PPP has led to multiple FDA clearances and product introductions in the TBI diagnostic product category where there was an urgent military and public need. Important lessons included defining the primary public and military health objective for new product introduction, the importance of the government\u2013academia\u2013industry PPP triad with a \u201ccollaboration towards solutions\u201d Quality-by-Design (QbD) mindset to assure clinical validity with regulatory compliance, the development of device comparators and integration of measurements into a robust, evidence-based statistical and FDA pathway, and the utility of top-down, flexible, practical action while operating within governmental guidelines and patient safety.<\/jats:p>","DOI":"10.1017\/cts.2022.373","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T07:43:53Z","timestamp":1646898233000},"source":"Crossref","is-referenced-by-count":5,"title":["The power of public\u2013private partnership in medical technology innovation: Lessons from the development of FDA-cleared medical devices for assessment of concussion"],"prefix":"10.1017","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8061-4923","authenticated-orcid":false,"given":"Michael E.","family":"Singer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dallas C.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-4258","authenticated-orcid":false,"suffix":"Jr.","given":"Daniel F.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"S2059866122003739_ref47","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2017.5004"},{"key":"S2059866122003739_ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2018.09.011"},{"key":"S2059866122003739_ref25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.090506.155819"},{"key":"S2059866122003739_ref37","doi-asserted-by":"publisher","DOI":"10.1002\/sim.8163"},{"key":"S2059866122003739_ref62","unstructured":"62. Critical To Quality - Six Sigma Terminology .Six Sigma Daily, 2013. (https:\/\/www.sixsigmadaily.com\/critical-to-quality\/)."},{"key":"S2059866122003739_ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2018.1428089"},{"key":"S2059866122003739_ref51","unstructured":"51. Singer, M. 510(k) Premarket Notification: Brainscope Company Inc.\u2019s Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid, K181179, 2018. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K181179.pdf)."},{"key":"S2059866122003739_ref10","unstructured":"10. Get the stats on traumatic brain injury in the United States, 2017. (https:\/\/www.brainline.org\/article\/get-stats-traumatic-brain-injury-united-states)."},{"key":"S2059866122003739_ref58","unstructured":"58. Harper, J. Austin Emphasizes Need to Help Companies Tech Cross Valley of Death. National Defense: NIDA\u2019s Business & Technology Magazine, 2021. (https:\/\/www.nationaldefensemagazine.org\/articles\/2021\/12\/4\/austin-emphasizes-need-to-help-companies-tech-cross-valley-of-death)."},{"key":"S2059866122003739_ref48","unstructured":"48. Singer, M. 510(k) Premarket Notification: Brainscope Company Inc.\u2019s Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid, K161068, 2016. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf16\/K161068.pdf)."},{"key":"S2059866122003739_ref18","doi-asserted-by":"publisher","DOI":"10.1097\/HTR.0000000000000187"},{"key":"S2059866122003739_ref43","unstructured":"43. Rothman, N , Jacquin, A , Dastidar, SG , et\u00a0al. Method and device for multimodal neurological evaluation, 2016. (https:\/\/patents.google.com\/patent\/US9269046)."},{"key":"S2059866122003739_ref30","unstructured":"30. Ben Dor, B. 510(k) Summary: InfraScan, Inc.\u2019s Infrascanner Model 2000, 2013. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf12\/k120949.pdf)."},{"key":"S2059866122003739_ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2015.00011"},{"key":"S2059866122003739_ref38","doi-asserted-by":"publisher","DOI":"10.1098\/rsta.2008.0043"},{"key":"S2059866122003739_ref9","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6609a1"},{"key":"S2059866122003739_ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdent.2018.04.022"},{"key":"S2059866122003739_ref53","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37349"},{"key":"S2059866122003739_ref56","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2016.08.44"},{"key":"S2059866122003739_ref17","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00572.2018"},{"key":"S2059866122003739_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acp006"},{"key":"S2059866122003739_ref32","unstructured":"32 Center for Devices and Radiological. Breakthrough Devices Program. US Food & Drug Administration, 2021. (https:\/\/www.fda.gov\/medical-devices\/how-study-and-market-your-device\/breakthrough-devices-program)."},{"key":"S2059866122003739_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2016.11.327"},{"key":"S2059866122003739_ref29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2005.069245"},{"key":"S2059866122003739_ref31","unstructured":"31. Lathan, C. 510(k) Summary: AnthroTronix, Inc.\u2019s DANA, 2014. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K141865.pdf)."},{"key":"S2059866122003739_ref46","unstructured":"46. Singer, M. 510(k) Premarket Notification: Brainscope Company Inc.\u2019s BrainScope Ahead 200, 2015. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf14\/K143643.pdf)."},{"key":"S2059866122003739_ref54","unstructured":"54. Singer, M. 510(k) Premarket Notification: Brainscope Company Inc.\u2019s Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid, K190815, 2019. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf19\/K190815.pdf)."},{"key":"S2059866122003739_ref55","doi-asserted-by":"publisher","DOI":"10.1002\/lrh2.10020"},{"key":"S2059866122003739_ref41","unstructured":"41. Prichep, LS , Rothman, NS , Oberly, DC , Singer, ME. Field deployable concussion assessment device, 2012. (https:\/\/patents.google.com\/patent\/US20120041330\/en)."},{"key":"S2059866122003739_ref16","first-page":"1","article-title":"Concussions and contracts: The National Football League\u2019s limitations to protecting its players from Chronic Traumatic Encephalopathy","volume":"33","author":"Wolpert","year":"2019","journal-title":"Journal of Law and Health"},{"key":"S2059866122003739_ref61","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.019541"},{"key":"S2059866122003739_ref23","unstructured":"23. Gleason, T. National Research Action Plan. Department of Defense, 2013, 56. (https:\/\/obamawhitehouse.archives.gov\/sites\/default\/files\/uploads\/nrap_for_eo_on_mental_health_august_2013.pdf)."},{"key":"S2059866122003739_ref59","unstructured":"59. BrainScope Receives ISO 13485 Certification. Brainscope, 2014. (https:\/\/www.brainscope.com\/all-pr\/2015\/8\/19\/brainscope-receives-iso-13485-certification-0)."},{"key":"S2059866122003739_ref15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/virtualmentor.2014.16.07.ecas1-1407","article-title":"Evaluating the risks and benefits of participation in high-school football","volume":"16","author":"O\u2019Brien","year":"2014","journal-title":"Virtual Mentor"},{"key":"S2059866122003739_ref19","unstructured":"19. American College of Emergency Physicians. Choosing Wisely, 2013. (https:\/\/www.choosingwisely.org\/societies\/american-college-of-emergency-physicians\/)."},{"key":"S2059866122003739_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurt.2009.10.022"},{"key":"S2059866122003739_ref39","first-page":"S83","article-title":"Specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests","volume":"29","author":"Florkowski","year":"2008","journal-title":"Clinical Biochemist Reviews"},{"key":"S2059866122003739_ref4","doi-asserted-by":"publisher","DOI":"10.3233\/NRE-2010-0553"},{"key":"S2059866122003739_ref42","unstructured":"42. Gormley, B. BrainScope collects $15.9M from military for TBI detection. Brainscope, 2014. (https:\/\/www.brainscope.com\/all-pr\/2015\/8\/19\/brainscope-collects-159m-from-military-for-traumatic-brain-injury-detection-0)."},{"key":"S2059866122003739_ref20","unstructured":"20. Moderate and Severe TBI. Centers for Disease Control and Prevention, 2021. (https:\/\/www.cdc.gov\/traumaticbraininjury\/moderate-severe\/index.html)."},{"key":"S2059866122003739_ref22","unstructured":"22. Hennessy, J. The brain: The final frontier? Stanford Magazine, 2014. (https:\/\/stanfordmag.org\/contents\/the-brain-the-final-frontier)."},{"key":"S2059866122003739_ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.559318"},{"key":"S2059866122003739_ref26","unstructured":"26. Singer, M. 510(k) Premarket Notification: Brainscope Company, Inc.\u2019s Non-Normalizing Quantitative Electroencephalograph Software, 2009. (https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/pmn.cfm?ID=K082886)."},{"key":"S2059866122003739_ref40","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13175"},{"key":"S2059866122003739_ref64","unstructured":"64. Preclinical Traumatic Brain Injury Common Data Elements .Federal Interagency Traumatic Brain Injury Research Informatic System, 2018. (https:\/\/fitbir.nih.gov\/content\/preclinical-common-data-elements)."},{"key":"S2059866122003739_ref49","unstructured":"49. BrainScope Receives Prix Galien Award Nomination for Its Concussion and Traumatic Brain Injury Assessment Product. Brainscope, 2018. (https:\/\/www.brainscope.com\/all-pr\/2018\/8\/2\/brainscope-receives-prix-galien-award-nomination-for-its-concussion-and-traumatic-brain-injury-assessment-product-1-0)."},{"key":"S2059866122003739_ref35","doi-asserted-by":"publisher","DOI":"10.1177\/2058460119855187"},{"key":"S2059866122003739_ref7","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2021.0048"},{"key":"S2059866122003739_ref27","unstructured":"27. Kessler, L , Phillips, P. Premarket Notification: A Key Element of US Medical Device Regulation. National Academies Press (US), 2010. (https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK209796\/)."},{"key":"S2059866122003739_ref33","unstructured":"33. BrainScope\u00ae announces concurrence with FDA on study design for its traumatic brain injury assessment device. Brainscope, 2011. (https:\/\/www.brainscope.com\/all-pr\/2015\/9\/3\/brainscope-announces-concurrence-with-fda-on-study-design-for-its-traumatic-brain-injury-assessment-device-0)."},{"key":"S2059866122003739_ref5","doi-asserted-by":"publisher","DOI":"10.1115\/1.4026364"},{"key":"S2059866122003739_ref28","unstructured":"28. Sullivan, T. Institute of Medicine Report Medical Devices and the Public\u2019s Health: The FDA 510(k) Clearance Process at 35 Years. Policy & Medicine, 2018. (https:\/\/www.policymed.com\/2011\/07\/institute-of-medicine-report-medical-devices-and-the-publics-health-the-fda-510k-clearance-process-a.html)."},{"key":"S2059866122003739_ref24","unstructured":"24. Hill, L. Researchers unite for warfighters at Combat Casualty Care conference. US Army Medical Research and Development Command, 2019. (https:\/\/mrdc.amedd.army.mil\/index.cfm\/media\/articles\/2010\/ATACCC_Conference_2010)."},{"key":"S2059866122003739_ref44","unstructured":"44. Isenhart, R , Jacquin, A , Prichep, L. Method and device for removing EEG artifacts, 2011. (https:\/\/patents.google.com\/patent\/US20110224569A1\/en)."},{"key":"S2059866122003739_ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2014.07.011"},{"key":"S2059866122003739_ref52","unstructured":"52. Singer, M. 510(k) Premarket Notification: Brainscope Company Inc.\u2019s Brain injury adjunctive interpretive electroencephalograph assessment aid, K181785, 2018. (https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf18\/K181785.pdf)."},{"key":"S2059866122003739_ref57","unstructured":"57. Clinical Quality-by-Design (QbD): Principles to Practice. Clinical Trials Transformation Initiative, 2015. (https:\/\/dcricollab.dcri.duke.edu\/sites\/NIHKR\/KR\/GR-Slides-08-21-15.pdf?Mobile=1&Source=%2Fsites%2FNIHKR%2F%5Flayouts%2F15%2Fmobile%2Fviewa%2Easpx%3FList%3D0095518e%2D671d%2D407a%2Da6a8%2De84adfd1316e%26View%3D1a5349ff%2D8bd1%2D4f91%2Dbc2d%2Daeed6b34b504%26ViewMode%3DDetail%26wdFCCState%3D1%26PageFirstRow%3D181)."},{"key":"S2059866122003739_ref11","unstructured":"11. Department Of State. The Office of Electronic Information B of PA. The Global War on Terrorism: The First 100 Days. (https:\/\/2001-2009.state.gov\/s\/ct\/rls\/wh\/6947.htm)."},{"key":"S2059866122003739_ref8","first-page":"1","article-title":"Estimating the global incidence of traumatic brain injury","volume":"130","author":"Dewan","year":"2018","journal-title":"Journal of Neurosurgery"},{"key":"S2059866122003739_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70028-0"},{"key":"S2059866122003739_ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s41231-019-0050-7"},{"key":"S2059866122003739_ref34","unstructured":"34. Glasgow Coma Scale. Centers for Disease Control and Prevention. (https:\/\/www.cdc.gov\/masstrauma\/resources\/gcs.pdf)."},{"key":"S2059866122003739_ref63","unstructured":"63. Machon, LW , Rothman, NS. Electrode array and method of placement, 2015. (https:\/\/patents.google.com\/patent\/US8989836B2\/en?oq=US+8%2c989%2c836+B2)."},{"key":"S2059866122003739_ref60","unstructured":"60. BrainScope Receives Frost & Sullivan Best Practices Award in Traumatic Brain Injury Assessment. Brainscope, 2017. (https:\/\/www.brainscope.com\/all-pr\/2017\/7\/10\/brainscope-receives-frost-sullivan-best-practices-award-in-traumatic-brain-injury-assessment-0)."}],"container-title":["Journal of Clinical and Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2059866122003739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T07:22:11Z","timestamp":1650612131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2059866122003739\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022]]}},"alternative-id":["S2059866122003739"],"URL":"https:\/\/doi.org\/10.1017\/cts.2022.373","relation":{},"ISSN":["2059-8661"],"issn-type":[{"value":"2059-8661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"e42"}}